Novel protein vaccine candidates against Group B streptococcal infection identified using alkaline phosphatase fusions

FEMS Microbiology Letters

Volumn 222, Issue 2, 2003, Pages 263-271

  Hughes, Martin J G ^a,e   Wilson, Rebecca ^a,d   Moore, Joanne C ^a   Lane, Jonathan D ^a   Dobson, Richard J ^a,f   Muckett, Phillip ^b,d   Younes, Zabin ^a   Pribul, Philippa ^a   Topping, Andrew ^c   Feldman, Robert G ^a,d,g   Santangelo, Joseph D ^a  

^a Microscience Ltd   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c Avecia LifeScience Molecules   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e F2G LTD   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^g Vmax   (United Kingdom)

Author keywords

Functional genomics; Group B streptococcus; Streptococcus agalactiae; Vaccine

Indexed keywords

ALKALINE PHOSPHATASE; BACTERIAL ANTIGEN; IMMUNOGLOBULIN G; VACCINE;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC SCREENING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE HOMOLOGY; SEROTYPE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 0038735506     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(03)00310-0     Document Type: Article

References (41)

1. Wilkinson H.W., Eagon R.G. Type-specific antigens of group B type Ic streptococci. Infect. Immun. 4:1971;596-604.
2. Wastfelt M., Stalhammer-Carlemalm M., Delisse A.M., Cabezon T., Lindahl G. Identification of a family of streptococcal surface proteins with extremely repetitive structure. J. Biol. Chem. 273:1996;18892-18897.
3. Russell-Jones G.J., Gotschlich E.C., Blake M.S. A surface receptor specific for human IgA on group B streptococci possessing the Ibc protein antigen. J. Exp. Med. 160:1984;1467-1475.
4. Rainard P., Lautrou Y., Sarradin P., Poutrel B. Protein X of Streptococcus agalactiae induces opsonic antibodies in cows. J. Clin. Microbiol. 29:1991;1842-1846.
5. Suvorov A.N., Flores A.E., Ferrieri P. Cloning of the glutamine synthase gene from group B streptococci. Infect. Immun. 65:1997;191-196.
6. Pancholi V., Fischetti V.A. Alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J. Biol. Chem. 273:1998;14503-14515.
7. Hammel, J., Brodeur, B., Marin, D. and Rioux, C. (December 1996) Streptococcal heat shock proteins members of the Hsp70 family. U.S. Patent WO9640928.
8. Brodeur B.R., Boyer M., Charlebois I., Hamel J., Couture F., Rioux C.R., Martin D. Identification of group B streptococci Sip protein, which elicits cross-protective immunity. Infect. Immun. 68:2000;5610-5618.
9. Hughes M.J.G., Moore J.C., Lane J.D., Wilson R., Pribul P., Younes Z.N., Dobson R.J., Everest P., Reason A.J., Redfern J.M., Greer F.M., Paxton T., Panico M., Morris H.R., Feldman R.G., Santangelo J.D. Identification of major outer surface proteins of Streptococcus agalactiae. Infect. Immun. 70:2002;1254-1259.
10. Pizza M., Scarlato V., Masignani V., Guiliani M.M., Arico B., Comanducci M., Jennings G.T., Baldi L., Bartolini E., Capecchi B., Galeotti C.L., Luzzi E., Manetti R., Marchetti E., Mora E., Nuti S., Ratti G., Santini L., Savino S., Scarselli M., Storni E., Zuo P., Broeker M., Hundt E., Knapp B., Blair E., Mason T., Tettelin H., Wood D.W., Jeffries A.C., Saunders N.J., Granoff D.M., Venter J.C., Moxon E.R., Grandi G., Rappuoli R. Identification of vaccine candidates against serogroup B meningococcus by whole genome sequencing. Science. 278:2000;1816-1820.
11. Hoffman C.S., Wright A. Fusions of secreted proteins to alkaline phosphatase: an approach for studying protein secretion. Proc. Natl. Acad. Sci. USA. 82:1985;5107-5111.
12. Manoil C., Makalanos J.J., Beckwith J. Alkaline phosphatase fusions: sensors of subcellular location. J. Bacteriol. 172:1990;158-161.
13. Calamia J., Manoil C. Lac permease of Escherichia coli: Topology and sequence elements promoting membrane insertion. Proc. Natl. Acad. Sci. USA. 87:1990;4937-4941.
14. Pearce B.J., Yin Y.B., Masure H.R. Genetic identification of exported proteins in Streptococcus pneumoniae. Mol. Microbiol. 9:1993;1037-1050.
15. Williams J.R., Ward J.M., Henderson B., Wilson M., Nair S.P. Rapid screening for putative exported proteins from Staphylococcus aureus using alkaline phosphatase as a reported molecule. Mol. Biotech. 15:2000;11-20.
16. Bina J.E., Nano F., Hancock R.E. Utilization of alkaline phosphatase fusions to identify secreted proteins, including potential efflux proteins and virulence factors from Helicobacter pylori. FEMS Microbiol. Lett. 148:1997;63-68.
17. Lim E.M., Rauzier J., Timm J., Torrea G., Murray A., Gicquel B., Portnoi D. Identification of Mycobacterium tuberculosis DNA sequences encoding exported proteins by using phoA gene fusions. J. Bacteriol. 177:1995;59-65.
18. Mintz K.P., Fives-Taylor P.M. Identification of genes encoding exported proteins of Actinobacillus actinomycetemcomitans. Infect. Immun. 67:1999;6217-6220.
19. Ward J., Fletcher J., Nair S.P., Wilson M., Williams R.J., Poole S., Henserson B. Identification of the exported proteins of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans by using alkaline phosphatase fusions. Infect. Immun. 69:2001;2748-2752.
20. Lee M.H., Nittayajarn A., Ross R.P., Rothschild C.B., Parsonage D., Clairborne A., Rubens C.E. Characterization of Enterococcus faecalis alkaline phosphatase and use in identifying Streptococcus agalactiae secreted proteins. J. Bacteriol. 181:1999;5790-5799.
21. Podbielski A., Spellerberg B., Woischnik M., Pohl B., Lutticken R. Novel series of plasmid vectors for gene inactivation and expression analysis in group A streptococci (GAS). Gene. 177:1996;137-147.
22. Shine J., Dalgarno L. The 3′-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites. Proc. Natl. Acad. Sci. USA. 71:1974;1342-1346.
23. Kling D.E., Madoff L.C., Michel J.L. Subcellular fractionation of group B streptococcus. BioTechniques. 27:1999;24-26.
24. Lancefield R.C. A serological differentiation of human and other groups of hemolytic streptococci. J. Exp. Med. 57:1932;571-595.
25. Moore J.C., Muckett P.J., Hughes M.J.G. Age-dependent presence of antibodies in rat dams, capable of conferring protection against group B streptococcus infection in neonates. FEMS Lett. 202:2001;125-127.
26. Wagner M., Wagner B., Kubin V.R. Immunoelectron microscopic study of the location of group-specific and type-specific polysaccharide antigens on isolated walls of group B streptococci. J. Gen. Microbiol. 120:1980;369-376.
27. Paoletti L.C., Ross R.A., Johnson K.D. Cell growth rate regulates expression of group B streptococcus type III capsular polysaccharide. Infect. Immun. 64:1996;1220-1226.
28. Guttormsen H.-K., Baker C.J., Brigsten A.K., Jennings H.J., Kasper D.L. Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines. J. Infect. Dis. 185:2002;1277-1284.
29. Rappouli R. Reverse vaccinology, a genome based approach to protein vaccinology. Vaccine. 19:2001;2688-2691.
30. Telford, J., Masignani, V., Margarit, Y., Ros, I., Grandi, G. and Fraser, C. (May 2002) Nucleic acids and proteins from streptotoccus groups A and B. U.S. Patent WO00234771.
31. Glasser P., Rusiniok C., Buchrieser C., Chevalier F., Frangeul L., Msadek T., Zouine M., Couve E., Lalioui L., Poyart C., Cuot P.T., Kunst F. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol. Microbiol. 45:2002;1499-1513.
32. Fischetti, V.A. (2000) Surface proteins on Gram-positive bacteria. P11-24. In: Fischetti, V.A., Novic, R.P., Ferretti, J.J., Portnoy, D.A. and Hood, J.I. (Eds.), Gram-Positive Pathogens. ASM Press, Washington, DC.
33. Higgins C.F. The ABC of channel regulation. Cell. 82:1995;693-696.
34. Burnie J.P., Matthews R.C., Carter T., Beaulieu E., Donohoe M., Chapman C., Williamson P., Hodgetts S.J. Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections. Infect. Immun. 68:2000;3200-3209.
35. Baichwal V., Liu D., Ames G.F.-L. The ATP-binding component of a prokaryotic traffic ATPase is exposed to the periplasmic (external) surface. Proc. Natl. Acad. Sci. USA. 90:1993;620-624.
36. Schneider H., Hunke S., Tebbe S. The MalK protein of the ATP-binding cassette transporter for maltose of Escherichia coli is accessible from the periplasmic side of the membrane. J. Bacteriol. 177:1995;5364-5367.
37. Gruis D.B., Price E.M. The nucleotide-binding folds of the cystic fibrosis transmembrane conductance regulator are extracellularly accessible. Biochemistry. 36:1997;7739-7745.
38. Ko Y.H., Dallanoy M., Pederson P.L. Cystic fibrosis transmembrane conductance regulator: the first nucleotide binding fold targets the membrane with retention of its ATP binding function. Biochemistry. 36:1997;5053-5064.
39. Clancy J.P., Hong J.S., Bebok Z., King S.A., Demolombe S., Bedwell D.M., Sorcher E.J. Cystic fibrosis transmembrance conductance regulator (CFTR) nucleotide-binding domain 1 (NDB1) and CFTR truncated within NBD1 target to the epithelial plasma membrane and increase anion permeability. Biochemistry. 37:1998;15222-15230.
40. Blott E.J., Higgins C.F., Linton K.J. Cysteine-scanning mutagenesis provides no evidence for the extracellular availability of the nucleotide-binding domains of the multidrug resistant transporter P-glycoprotein. EMBO J. 18:1999;6800-6808.
41. Gase K., Gase A., Schirmer H., Malke H. Cloning, sequencing and functional overexpression of the Streptococcus equisimilis H46A gapC gene encoding a glyceraldehydes-3-phosphate dehydrogenase that also functions as a plasmin(ogen)-binding proteins: Purification and biochemical characterization of the protein. Eur. J. Biochem. 239:1996;42-51.